Bioequivalence Study of Capsule and Tablet Formulations of TA-8995
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetics of capsule and tablet
formulations of TA-8995 in healthy male subjects aged 18 to 55 years.